301015.SZ
Qingdao Baheal Medical, Inc.
SZSE · Healthcare · F 批发零售 · CN
CNY 23.79
+0.81%Year over year
Reported trailing growth
- Revenue
- -7.9%
- EBITDA
- —
- EBIT
- -8.2%
- EPS
- -12.5%
- Free cash flow
- -40.7%
- Operating cash flow
- -24.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -0.0%
- EBITDA
- +5.8%
- EBIT
- +3.0%
- Net income
- -2.1%
- EPS
- -2.1%
- Free cash flow
- +47.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026